Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06782529 | RECRUITING | Osteoarthritis of Knee

Knee Injections for Obese Patients With Knee Arthritis
Sponsor:

Mayo Clinic

Information provided by (Responsible Party):

Jeff P. Nadwodny

Brief Summary:

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

Condition or disease

Osteoarthritis of Knee

Intervention/treatment

Triamcinolone Acetonide Low Dose

Triamcinolone Acetonide Standard Dose

Phase

PHASE4

Study Type : INTERVENTIONAL
Estimated Enrollment : 40 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Comparison of Varying Doses of Steroid for Intra-articular Knee Injections
Actual Study Start Date : 2025-01-24
Estimated Primary Completion Date : 2026-01-24
Estimated Study Completion Date : 2026-03-24

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 55 Years to 85 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • • Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis.
Exclusion Criteria
  • * BMI \< 30 kg/m2
  • * Uncontrolled diabetics with a hemoglobin A1c \> 8%
  • * No other treatment within the time frame of the study.
  • * Patients that are undergoing physical therapy at the time of the study.
Knee Injections for Obese Patients With Knee Arthritis

Location Details

NCT06782529

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Florida

Mayo Clinic in Florida

Jacksonville, Florida, United States, 32224